QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bone-biologics-ceo-issues-stockholder-letter-highlighting-nb1-clinical-progress-product-improvements-year-end-enrollment-goal-expanded-shelf-life-interim-trial-update-and-2026-financial-outlook

One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year under our cost-efficient busine...

 bone-biologics-q2-eps-133-misses-058-estimate

Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0....

 why-is-bone-biologics-stock-surging-on-friday

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regene...

Core News & Articles

Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))), a developer of orthobiol...

Core News & Articles
Market-Moving News for June 27th
06/27/2025 11:22:38

NKE: 11% | Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport ...

 bone-biologics-corp-for-mixed-shelf-of-up-to-35m

– SEC Filing

 bone-biologics-approves-plan-amendment-to-increase-shares-by-30m

-SEC Filing

 watching-bone-biologics-zacks-small-cap-research-gives-stock-1650-price-valuation

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_05132025_BBLG_Sorensen.pdf

 bone-biologics-q1-eps-032-beats-048-estimate

Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.48...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION